CSi001-A

Cell Line

Provider

External Databases

General Information

• Auer F et al. Activation-induced cytidine deaminase prevents pro-B cell acute lymphoblastic leukemia by functioning as a negative regulator in Rag1 deficient pro-B cells. Oncotarget. 2017 Sep 29;8(44):75797-75807.
• Raboso-Gallego J et al. Lineage choice decisions in B-cell development and leukemia. Stem cell investigation. 2018;5:46.
• Rodríguez-Hernández G et al. T-cell leukemogenesis is an inappropriate lineage decision-making process: implications for precision oncology. Molecular & cellular oncology. 2018;5(4):e1497860.
• Martín-Lorenzo A et al. Loss of Pax5 Exploits Sca1-BCR-ABL(p190) Susceptibility to Confer the Metabolic Shift Essential for pB-ALL. Cancer research. 2018 May 15;78(10):2669-2679.
• García-Ramírez I et al. Lmo2 expression defines tumor cell identity during T-cell leukemogenesis. The EMBO journal. 2018 Jul 13;37(14).
• Zhao Z et al. Generation of CSi001-A, a transgene-free, induced pluripotent stem cell line derived from a Parkinson Disease (PD) patient. Stem cell research. 2018 Dec;33:1-5.
• Vicente-Dueñas C et al. Dnmt1 links BCR-ABLp210 to epigenetic tumor stem cell priming in myeloid leukemia. Leukemia. 2019 Jan;33(1):249-278.
• Wang AYL et al. Episomal Induced Pluripotent Stem Cells: Functional and Potential Therapeutic Applications. Cell transplantation. 2019 Dec;28(1_suppl):112S-131S.
• Rodríguez-Hernández G et al. Infectious stimuli promote malignant B-cell acute lymphoblastic leukemia in the absence of AID. Nature communications. 2019 Dec 5;10(1):5563.
• Rodríguez-Hernández G et al. The Second Oncogenic Hit Determines the Cell Fate of ETV6-RUNX1 Positive Leukemia. Frontiers in cell and developmental biology. 2021;9:704591.
• Ray A et al. An Overview on Promising Somatic Cell Sources Utilized for the Efficient Generation of Induced Pluripotent Stem Cells. Stem cell reviews and reports. 2021 Dec;17(6):1954-1974.

General